IL188175A0 - 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate - Google Patents
2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleateInfo
- Publication number
- IL188175A0 IL188175A0 IL188175A IL18817507A IL188175A0 IL 188175 A0 IL188175 A0 IL 188175A0 IL 188175 A IL188175 A IL 188175A IL 18817507 A IL18817507 A IL 18817507A IL 188175 A0 IL188175 A0 IL 188175A0
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- pyridinylamino
- thiazolidinedione
- ethoxy
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2006/017994 WO2007130064A1 (fr) | 2006-05-09 | 2006-05-09 | Acide 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione)butanedioique, procedes de preparation et compositions a base de maleate de rosiglitazone |
Publications (1)
Publication Number | Publication Date |
---|---|
IL188175A0 true IL188175A0 (en) | 2008-03-20 |
Family
ID=38668055
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL188175A IL188175A0 (en) | 2006-05-09 | 2007-12-17 | 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
IL199822A IL199822A0 (en) | 2006-05-09 | 2009-07-13 | Sealed package of pharmaceutical composition comprising 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL199822A IL199822A0 (en) | 2006-05-09 | 2009-07-13 | Sealed package of pharmaceutical composition comprising 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP2009536643A (fr) |
CN (1) | CN101426789A (fr) |
BR (1) | BRPI0621551A2 (fr) |
CA (1) | CA2647829A1 (fr) |
IL (2) | IL188175A0 (fr) |
MX (1) | MX2008014298A (fr) |
NO (2) | NO20085124L (fr) |
WO (1) | WO2007130064A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010013141A2 (fr) * | 2008-08-01 | 2010-02-04 | Actavis Group Ptc Ehf | Hydrogénosulfate de rosiglitazone essentiellement pur |
CN102863436B (zh) * | 2012-06-19 | 2018-02-09 | 重庆医科大学 | 噻唑烷二酮类衍生物及其制备和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5741803A (en) * | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
-
2006
- 2006-05-09 JP JP2009509523A patent/JP2009536643A/ja not_active Withdrawn
- 2006-05-09 MX MX2008014298A patent/MX2008014298A/es unknown
- 2006-05-09 CA CA002647829A patent/CA2647829A1/fr not_active Abandoned
- 2006-05-09 CN CNA2006800543976A patent/CN101426789A/zh active Pending
- 2006-05-09 WO PCT/US2006/017994 patent/WO2007130064A1/fr active Application Filing
- 2006-05-09 BR BRPI0621551A patent/BRPI0621551A2/pt not_active IP Right Cessation
-
2007
- 2007-12-17 IL IL188175A patent/IL188175A0/en unknown
-
2008
- 2008-12-09 NO NO20085124A patent/NO20085124L/no not_active Application Discontinuation
-
2009
- 2009-06-19 NO NO20092362A patent/NO20092362L/no not_active Application Discontinuation
- 2009-07-13 IL IL199822A patent/IL199822A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20085124L (no) | 2009-02-04 |
IL199822A0 (en) | 2011-07-31 |
WO2007130064A1 (fr) | 2007-11-15 |
NO20092362L (no) | 2009-02-04 |
CA2647829A1 (fr) | 2007-11-15 |
MX2008014298A (es) | 2008-11-26 |
CN101426789A (zh) | 2009-05-06 |
BRPI0621551A2 (pt) | 2016-08-16 |
JP2009536643A (ja) | 2009-10-15 |
WO2007130064A8 (fr) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL220212A (en) | Derivatives 5 - [(2-Aminopyrimide-4-Yl) Methylidan] -3,1-Thiazolidine-4,2-Discussion and Pharmaceutical Preparations Containing Them | |
IL223002A0 (en) | Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide | |
IL195882A (en) | Crystalline forms of derivatives of (1 s) –1, 5 – anhydro – 1– c - (3 - ((phenyl) methyl) phenyl) - d -glucitol with amino acids and their use in the treatment of diabetes | |
IL184427A0 (en) | Thiazole-4-carboxamide derivatives as mglur5 antagonists | |
SG155222A1 (en) | Thiazole based inhibitors of atp-utilizing enzymes | |
PL384446A1 (pl) | Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania | |
IL185759A0 (en) | Pharmaceutical preparation of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide | |
IL206470A (en) | 2-Amino-1 - ((Phosphonooxy) Methyl) -3 - (3 - ((4 - ((2-Pyridinyloxy) Methyl) Phenyl) Methyl) -5-Isoxazolyl) - Pyridinium and Pharmaceutical Preparation Containing It | |
IL195348A0 (en) | Crystalline form of (trans-4-[({5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl}carbonyl)amino]phenyl}cyclohexyl)acetic acid | |
IL193670A0 (en) | A new crystalline form g of (5s)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonyl-methyl]-5-methyl-imidazolidine-2,4-dione (i) and intermediates thereof | |
IL267557B (en) | Process for the preparation of 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl[ethoxy]phenyl]methyl]-2,4-thiazolidinedione and their salts | |
IL155036A0 (en) | Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same | |
IL188175A0 (en) | 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate | |
HUE054346T2 (hu) | 5-[[4-[2-[5-(1-Hidroxietil)piridin-2-il]etoxi]fenil]metil]-1,3-tiazolidin-2,4-dion nem-alkoholos zsírmáj-betegség kezelésére | |
CY2200159T2 (el) | 2-ν-{5-[[4-[2-μεθυλ-2-πυριδινυλαμινο)αιθοξυ]φαινυλ]μεθυλ]-2-4-θειαζολιδινοδιονο} βουτανιοδιοϊκο οξυ, μεθοδοι παρασκευης και συνθεσεις με μηλεϊνικη ροζιγλιταζονη | |
HUP0600347A2 (en) | Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon) and the intermediate | |
PL385697A1 (pl) | Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania | |
HU0600868D0 (en) | 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation | |
WO2010013141A3 (fr) | Hydrogénosulfate de rosiglitazone essentiellement pur | |
AU2003269483A1 (en) | Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione | |
EA200700568A1 (ru) | Способ получения розиглитазона | |
WO2008010089A3 (fr) | Procédé pour préparer des intermédiaires de la rosiglitazone, rosiglitazone et nouvelles formes polymorphes de celle-ci | |
EP2451803A4 (fr) | Procédé d'élaboration de dérivé de 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phényl]-1,3-oxazolidin-5-yl}méthyl)thiophèn-2-carboxamide et intermédiaire utilisé à cet effet | |
EP2332923A4 (fr) | Procédé de fabrication de la 5-[2-(méthylthio)éthoxy] et pyrimidine-2-amine | |
EA200900647A1 (ru) | Новые кристаллические формы |